Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 4/20 | 0.37 |
| ▸ | CA2 | P00918 | 5/20 | 0.33 |
| ▸ | CA12 | O43570 | 4/20 | 0.31 |
| ▸ | CA9 | Q16790 | 4/20 | 0.31 |
| ▸ | CA1 | P00915 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4618909 | 1.00 | ABCB1 (0.37) | ABCB1CA2CA12CA9CA1 | |
| SCHEMBL13722831 | 0.87 | CA2 (0.30) | CA2 | |
| SCHEMBL9744786 | 0.85 | ABCB1 (0.40) | ABCB1CA2CA12CA9CA1 | |
| SCHEMBL9744773 | 0.85 | ABCB1 (0.40) | ABCB1CA2CA12CA9CA1 | |
| SCHEMBL9744999 | 0.85 | ABCB1 (0.40) | ABCB1CA2CA12CA9CA1 | |
| SCHEMBL6834890 | 0.81 | ABCB1 (0.38) | ABCB1 | |
| SCHEMBL14853819 | 0.81 | CA9 (0.31) | CA2CA12CA9CA1 | |
| SCHEMBL6834894 | 0.81 | ABCB1 (0.38) | ABCB1 | |
| SCHEMBL21694329 | 0.81 | ABCB1 (0.38) | ABCB1 | |
| SCHEMBL14536755 | 0.81 | PRKCA (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1882748-A2 | A population of nucleic acids including a subpopulation of LNA oligomers | Exiqon A/S (DK) | 2008-01-30 | — | — | EP | disclosed |
| US-20060147924-A1 | Population of nucleic acids including a subpopulation of lna oligomers | EXIQON A/S (DK) | 2006-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060147924-A1 | Population of nucleic acids including a subpopulation of lna oligomers | NSUN2, NCL, RNGTT | ABCB1 1339/4885CA2 3624/4885CA12 4184/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.